Biotech: Page 40
-
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool executive appointments and promotions in the healthcare industry Pharma Pool DR. UDIT BATRA EMD Millipore Introduces CEO and President EMD Millipore, the life-sciences division of Merck KGaA, has appointed Udit Batra, Ph.D., as president and CEO, responsible for the organization’s str...
By Ann Grey • May 29, 2014 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar Industry Events and Conferences, including Special Discounts Coming Attractions This year marks the 50th Anniversary of the DIA Annual Meeting, the largest multidisciplinary event that brings together a global network of life-sciences professionals to foster innovation that will lead...
By Heather Hummel • May 29, 2014 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Malaysia Focuses on Growth with Healthcare a Top Priority
Malaysia presents an attractive market to pharmaceutical companies thanks to growing government support, good infrastructure, and a trusted manufacturing environment. Malaysia is a federal constitutional monarchy with a population of about 29 million and an open and growing economy. According to ...
By Kim Ribbink • April 28, 2014 -
PharmaVoice Team/PharmaVoice
HBA's 2014 Rising Stars
Joyce Acbay Senior Director, Regulatory Affairs Actelion Pharmaceuticals Joyce is passionate about mentoring women and helping others reach their professional goals. Lorrie Albinson Associate Director, Sales Training and Development Actavis Brand Sales Actavis Lorrie is a distinguished leader at ...
By Taren Grom • April 28, 2014 -
PharmaVoice Team/PharmaVoice
Pharma Doors Begin to Open in Indonesia
Pharma Doors Begin to Open in Indonesia By Kim Ribbink Though many challenges continue for pharma companies bringing products to market in Indonesia, a growing middle class and improving healthcare access make it a desirable market. Indonesia is the world’s fourth largest country in terms of popu...
By Kim Ribbink • March 27, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Albert BOURLA Susan SILBERMANN Pfizer Makes Executive Moves Pfizer has named Albert Bourla as group president of the vaccines, oncology, and consumer healthcare business. Mr. Bourla has 20 years of experience at Pfizer and has held senior global positions across a range of markets and...
By Ann Grey • Feb. 25, 2014 -
PharmaVoice Team/PharmaVoice
On the Calendar
On the Calendar The Calendar Industry Events and Conferences, including special discounts Coming Attractions In May 2014, the Healthcare Businesswomen’s Association is celebrating the 25th anniversary of its prestigious Woman of the Year (WOTY) award. The HBA is proud to announce that three vis...
By Heather Hummel • Feb. 25, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Outsourcing: Adding Value to the Model
SHOWCASE FEATURE: Outsourcing: Outsourcing: Adding Value to the Model By Tarem Grom, Editor Outsourcing has become a standard worldwide business practice and management imperative and stakeholders are looking for more than cost- savings. A relatively small number of BPO clients — 20% of those par...
By Taren Grom • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
C-Suite: Biotechnology
Biotechnology C-suite executives identify the biggest opportunities for innovation as well as the biggest barriers. Lloyd Everson, M.D CEO MolecularHealth Opportunities: The greatest opportunity for innovation within the biotechnology space lies in the rapidly increasing amount of data furthering...
By Taren Grom • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Singapore a Pharma Hub for Asia
Singapore a Pharma Hub for Asia By Kim Ribbink The pharma industry is increasingly drawn to Singapore, thanks to its commitment to research and innovation, good talent base, and trusted regulatory and IP environment. Singapore is fast becoming a leading regional and even global center for the lif...
By Kim Ribbink • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Global Regulations Becoming More Uniform
Pharmaceutical companies must navigate a changing regulatory environment both here and abroad. As the digital age brings the clinical world closer together and research and development become more global, the industry needs to find a way to address regulatory requirements across myriad regions. T...
By Denise Myshko • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Specialty Drugs: An Evolving Commercial Model
A changing marketplace creates new challenges and new business models for specialty medications. At the same time the industry is increasing its focus on developing specialty drugs — a projected 40% growth by 2014 and 67% by 2015, according to Express Scripts — the reimbursement, marketing, and s...
By Robin Robinson • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Last Word
Biopharmaceutical companies are becoming more fully engaged with patients as well as patient advocacy groups. Millennium’s head of patient advocacy, Tom Sellers, discusses the barriers and opportunities that early engagement entails. PV:What has precluded biopharmaceutical companies from early ...
By Tom Sellers • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Dr. Yong-Jun LIU Medimmune Names New Head of Research MedImmune, the global biologics research and development arm of AstraZeneca, has named Yong-Jun Liu, M.D., Ph.D., as the company’s new head of research. Most recently, Dr. Liu served as VP and chief scientific officer at the Baylo...
By Ann Grey • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
The Philippines: Global Pharma Appeal
With 14 of the top 20 pharma companies establishing manufacturing facilities in the Philippines, the country is clearly a go-to destination. The Philippines, an island nation in Southeast Asia, has a population of more than 95 million people, making it the 12th most populated country in the world...
By Kim Ribbink • Dec. 28, 2013 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Pharma Pool Greg Barrett Dr. Glenn Gormley Daiichi Sankyo Makes Two New Executive Appointments Greg Barrett has been appointed as the new acting head of the Commercial Division of Daiichi Sankyo. He holds the new title of acting president, Daiichi Sankyo Administrative & Commercia...
By Ann Grey • Dec. 28, 2013 -
PharmaVoice Team/PharmaVoice
R&D Trends: The Innovation Challenge
The Innovation Challenge Innovation continues to be a hot topic in pharma R&D. But developing truly innovative medicines will require companies to embrace nontraditional partnerships, have a focus on genomics to get a better understanding of disease, and adopt systems biology and big data app...
By Taren Grom • Nov. 12, 2013 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Jesper Høiland Novo Nordisk Appoints New Leader of North American Affiliate Jesper Høiland has been named as president of Novo Nordisk Inc., the company’s North American affiliate. Mr. Høiland was previously Novo Nordisk’s head of International Operations where he oversaw all of the c...
By Ann Grey • Nov. 12, 2013 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar MHealthSummit — where technology, business, research, and policy connect. The largest event of its kind, the fifth annual mHealth Summit, December 8-11, 2013, Gaylord National Resort and Convention Center, Washington, D.C., brings together leaders in government, the private sector, i...
By Heather Hummel • Nov. 12, 2013 -
PharmaVoice Team/PharmaVoice
What's New
TrendIng Now: Strategic initiative helps clients with changes to U.S. healthcare policy. New Healthcare-related Products, Services, and Companies Featured Briefs: inVentiv Health and Mehlman Vogel Castagnetti Launch Breakaway Policy Strategies FDA Forms Program Alignment Group INC Research Offers...
By Ann Grey • Nov. 12, 2013 -
PharmaVoice Team/PharmaVoice
UpFront
INDUSTRY at Large Lilly’s Global Day of Service Supports Indy DO Day Initiative Counterfeit Medicines: The New Face of Organized Crime Veeva Goes IPO In Memoriam Kathleen Drennan Awards… Genentech Researcher Receives Albert Lasker Award PhRMA Honors Vaccines Pioneers Wolters Kluwer wins Awards Po...
By Denise Myshko • Nov. 12, 2013 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
2014 — Year in Preview From the ACA to social media, industry executives are providing their predictions on what’s hot for 2014. For this special annual issue of PharmaVOICE, we invited dozens of industry experts to provide their predictions on the emerging and current trends they expect to impac...
By Taren Grom • Nov. 12, 2013 -
PharmaVoice Team/PharmaVoice
Oh Canada, Land of Pharma Opportunity
Oh Canada, Land of Pharma Opportunity A research leader with a strong healthcare network, a stable democracy, a rich talent resource, Canada remains a powerful draw for the pharma industry. The second largest country in the world, based on land mass, Canada enjoys a strong economy and extensive d...
By Kim Ribbink • Sept. 27, 2013 -
PharmaVoice Team/PharmaVoice
HIV Prevention Makes Strides
HIV Prevention Makes Strides New research is leading to vaccines and other pre-exposure prophylaxis therapies against HIV/AIDS. A modern day plague unchecked. That’s how the Centers for Disease Control describes HIV/AIDS. HIV, along with malaria and tuberculosis, represents a huge area of unmet n...
By Denise Myshko • Sept. 27, 2013 -
PharmaVoice Team/PharmaVoice
Talent Pool
BIOTECH POOL Kelly BLACKBURN aTyr Pharma Expands Leadership Team aTyr Pharma has expanded its executive leadership team. Kelly Blackburn joins aTyr as VP, clinical affairs. Ms. Blackburn was formerly VP, clinical development operations, at Vertex Pharmaceuticals, where she was responsible for the...
By Ann Grey • Sept. 27, 2013
Previous
